<DOC>
	<DOCNO>NCT00000329</DOCNO>
	<brief_summary>The purpose study assess abuse liability examine reinforce effect intravenous buprenorphine buprenorphine/naloxone combination buprenorphine-naloxone maintain volunteer</brief_summary>
	<brief_title>Buprenorphine/Naloxone Treatment Opioid Dependence-Experiment II-1 - 4</brief_title>
	<detailed_description>Ongoing study - result available time</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Individuals must least 18 yrs age , currently opioid dependent meet FDA criterion narcotic maintenance treatment . Comorbid substance abuse dependence disorder may also present . Individuals must healthy despite drug dependency history IV opioid use . Individuals evidence anti active Diagnostic Statistical Manual Mental Disorders ( DSMIV ) Axis I psychiatric disorder ( e.g . psychosis , manicdepressive illness , organic psychiatric disorder ) , significant medical illness ( e.g . liver cardiovascular disease ) pregnant female subject exclude study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>drug dependence</keyword>
</DOC>